“…In addition to the aforementioned type of genes that have been introduced into rLCMV systems, an important usage of rLCMV, especially the r3LCMV systems, has been the development of a variety of rLCMVs that stably express nonfluorescent reporters such as CAT (104,115,116) as well as fluorescent reporter genes. These include the replacement of wild-type viral GPC or NP segments with eGFP (104,106,107,(114)(115)(116)(117)(118)(119)(120)(121)(122)(123)(124), teal fluorescent protein (125), mCherry (126,127), or ZsGreen (128)(129)(130). Not only do these reporters allow for assessment of viral replication in less time than is needed for traditional plaque assays, but also they have been a powerful tool in highthroughput screening approaches used to identify small-molecule antivirals (131), identification of receptors required for host cell infection (126), and the discovery that LCMV can cause long-term immune dysfunction months after infection (125), among many other important discoveries.…”